There was an abundance of promising new research that came out of the 2023 San Antonio Breast Cancer Symposium. Here are some highlights for metastatic breast cancer. Be sure to check out our early-stage highlights.

CBCN had the pleasure of attending the San Antonio Breast Cancer Symposium in December. Below you’ll find the latest research for early-stage breast cancer. Watch out for the latest research on mBC.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held in April 2021. In this session, Dr. Karen Gelmon, MD, FRCPC, a Medical Oncologist, answered questions about HER2-positive breast cancer. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

I remember sitting in the small room waiting for the doctor to come in.  I was nervous but didn’t think anything was wrong.  The doctor came in and asked how I was.  I gave my usual cheery response that everything was good but added that “it depended on what he was going to tell me…ha ha ha”.  I laughed but my jovial manner quickly subsided when my doctor sat down and the words “it’s not good” came out.  My heart dropped.  He then said, “It’s cancer”.  My heart dropped again.

People have known about breast cancer since ancient times.  For most of that time, there were no effective treatments.  However, in the last 120 years, advances in surgical and medical treatments have meant that today, 98 percent of patients with localized breast cancer survive at least five years after diagnosis.  The following timeline shows the development of breast cancer treatments.

Every year clinicians, researchers, patient advocates and industry members head to Texas to share the latest breakthroughs in breast cancer research. It’s a key conference to learn about new treatments or new standards of care for breast cancer patients. Here’s some of the highlights that have the most impact on patient care today:

Adriana Capozzi of Bradford, Ontario, was diagnosed in October 2014 with HER2-positive, Stage III breast cancer.  She received four months of chemotherapy and one year of Herceptin, along with a bilateral mastectomy and 25 rounds of radiation.

My life changed forever once I received the phone call no one wants to get early one morning in March 2015. My surgeon was on the other line with the results from my recent biopsy. The lump that was supposed to be only a pesky cyst was indeed cancerous. The surgeon further explained my diagnosis. But the only thing I heard was that I had cancer. My world felt like it was spinning out of control.